Cytosorbents Corp (NASDAQ:CTSO)

5.49
Delayed Data
As of Sep 13
 +0.18 / +3.39%
Today’s Change
3.68
Today|||52-Week Range
13.95
-32.05%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$152.5M

Company Description

CytoSorbents Corp. engages in the research and development of blood purification technology for the reduction of deadly uncontrolled inflammation in hospitalized patients. Its product include CytoSorb, ContrastSorb, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.

Contact Information

CytoSorbents Corp.
7 Deer Park Drive
Monmouth Junction New Jersey 08852
P:(732) 329-8885
Investor Relations:
17323298885394

Employees

Shareholders

Individual stakeholders22.57%
Other institutional14.58%
Mutual fund holders11.97%

Top Executives

Phillip P. ChanPresident, Chief Executive Officer & Director
Vincent J. CapponiChief Operating Officer
Kathleen P. BlochCFO, Secretary & Chief Accounting Officer
Eric G. MortsensonChief Medical Officer
Christopher CramerVice President-Business Development